Background. Radiation, including radiation therapy (RT) for a variety of conditions, is known to be a lung carcinogen. Methods. Data from the Surveillance, Epidemiology, and End Results program of the National Cancer Institute for 1973-1986 were utilized to investigate whether RT for breast cancer
β¦ LIBER β¦
Lung cancer after radiation therapy for breast cancer
β Scribed by I. Aref; P. Cross; T. Bichay; B. Nair; Alfred I. Neugut
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 231 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lung cancer after radiation therapy for
β
Alfred I. Neugut; Won Chul Lee; Todd Murray; Eliezer Robinson; Kevin Karwoski; G
π
Article
π
1993
π
John Wiley and Sons
π
English
β 380 KB
π 2 views
When not to give radiation therapy after
β
John De Csepel; Paul I. Tartter; Csaba Gajdos
π
Article
π
2000
π
John Wiley and Sons
π
English
β 105 KB
π 1 views
Breast cancerβPreoperative and postopera
β
William E. Powers
π
Article
π
1969
π
John Wiley and Sons
π
English
β 475 KB
π 1 views
Clinical trials of adjuvant radiation th
β
A. Raventos
π
Article
π
1977
π
John Wiley and Sons
π
English
β 358 KB
π 1 views
Rebound response after estrogen therapy
β
Richard W. Nesto; Blake Cady; Richard A. Oberfield; Artemis G. Pazianos; Ferdina
π
Article
π
1976
π
John Wiley and Sons
π
English
β 305 KB
π 1 views
Circulating thrombomodulin during radiat
β
Martin Hauer-Jensen; Feng-Ming Kong; Louis M. Fink; Mitchell S. Anscher
π
Article
π
1999
π
John Wiley and Sons
π
English
β 125 KB
π 1 views
The endothelial cell glycoprotein, thrombomodulin (TM), is an important physiological anticoagulant. TM is downregulated and released from the cell membrane into the circulation by ionizing radiation and during inflammation. The present study measured plasma TM in 17 patients before, during, and aft